These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8898111)
1. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. Kim KS; Rajarathnam K; Clark-Lewis I; Sykes BD FEBS Lett; 1996 Oct; 395(2-3):277-82. PubMed ID: 8898111 [TBL] [Abstract][Full Text] [Related]
2. Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy. Meunier S; Bernassau JM; Guillemot JC; Ferrara P; Darbon H Biochemistry; 1997 Apr; 36(15):4412-22. PubMed ID: 9109648 [TBL] [Abstract][Full Text] [Related]
3. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. Proost P; Wuyts A; Van Damme J J Leukoc Biol; 1996 Jan; 59(1):67-74. PubMed ID: 8558070 [TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. Franci C; Wong LM; Van Damme J; Proost P; Charo IF J Immunol; 1995 Jun; 154(12):6511-7. PubMed ID: 7759884 [TBL] [Abstract][Full Text] [Related]
6. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody. Reid C; Rushe M; Jarpe M; van Vlijmen H; Dolinski B; Qian F; Cachero TG; Cuervo H; Yanachkova M; Nwankwo C; Wang X; Etienne N; Garber E; Bailly V; de Fougerolles A; Boriack-Sjodin PA Protein Eng Des Sel; 2006 Jul; 19(7):317-24. PubMed ID: 16682434 [TBL] [Abstract][Full Text] [Related]
7. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. Uguccioni M; Loetscher P; Forssmann U; Dewald B; Li H; Lima SH; Li Y; Kreider B; Garotta G; Thelen M; Baggiolini M J Exp Med; 1996 May; 183(5):2379-84. PubMed ID: 8642349 [TBL] [Abstract][Full Text] [Related]
8. Chemokines as targets for pharmacological intervention. Sozzani S; Allavena P; Proost P; Van Damme J; Mantovani A Prog Drug Res; 1996; 47():53-80. PubMed ID: 8961764 [No Abstract] [Full Text] [Related]
9. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Opdenakker G; Froyen G; Fiten P; Proost P; Van Damme J Biochem Biophys Res Commun; 1993 Mar; 191(2):535-42. PubMed ID: 8461011 [TBL] [Abstract][Full Text] [Related]
10. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113 [TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines. Proost P; Van Leuven P; Wuyts A; Ebberink R; Opdenakker G; Van Damme J Cytokine; 1995 Feb; 7(2):97-104. PubMed ID: 7780043 [TBL] [Abstract][Full Text] [Related]
12. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. Sarafi MN; Garcia-Zepeda EA; MacLean JA; Charo IF; Luster AD J Exp Med; 1997 Jan; 185(1):99-109. PubMed ID: 8996246 [TBL] [Abstract][Full Text] [Related]
14. Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine. Salanga CL; Dyer DP; Kiselar JG; Gupta S; Chance MR; Handel TM J Biol Chem; 2014 May; 289(21):14896-912. PubMed ID: 24727473 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. Fernandez EJ; Wilken J; Thompson DA; Peiper SC; Lolis E Biochemistry; 2000 Oct; 39(42):12837-44. PubMed ID: 11041848 [TBL] [Abstract][Full Text] [Related]
17. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Blaszczyk J; Coillie EV; Proost P; Damme JV; Opdenakker G; Bujacz GD; Wang JM; Ji X Biochemistry; 2000 Nov; 39(46):14075-81. PubMed ID: 11087354 [TBL] [Abstract][Full Text] [Related]
18. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2. Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301 [TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. Bonini JA; Martin SK; Dralyuk F; Roe MW; Philipson LH; Steiner DF DNA Cell Biol; 1997 Oct; 16(10):1249-56. PubMed ID: 9364936 [TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B). Yamagami S; Tanaka H; Endo N FEBS Lett; 1997 Jan; 400(3):329-32. PubMed ID: 9009224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]